We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
As the desperate search for a COVID-19 treatment continues, two phase 3 trials in China of Gilead’s remdesivir as a treatment have been suspended due to the lack of eligible patients. Meanwhile, multiple trials of the drug in the U.S. and Europe are going forward. Read More
The World Health Organization (WHO) has reported that there are 70 novel coronavirus vaccines in development around the globe with three already in human trials. Read More
Gilead’s antiviral drug remdesivir showed clinical improvement in two-thirds of COVID-19 patients in a study at Los Angeles’ Cedars-Sinai Hospital. Read More
Eli Lilly’s arthritis treatment Olumiant (baricitinib) is being investigated as a potential COVID-19 treatment in one arm of a National Institutes for Allergy and Infectious Diseases adaptive trial. Read More